Patient advocates, congressional staff and researchers to discuss how the federal government can increase clinical trials awareness
Patient advocates, congressional staff and researchers to discuss how the federal government can increase clinical trials awareness
Washington, DC – The Coalition for Clinical Trials Awareness (CCTA), of which the Alliance for Patient Access is the managing member, will host a Capitol Hill policy roundtable on Wednesday, May 3, “How Can the Federal Government Increase Clinical Trials Awareness?” The event, offering perspectives from patient advocates, an FDA official and a researcher, will discuss how the federal government can develop a strategy to increase clinical trials awareness and address the clinical trials under-enrollment problem. Congresswoman Diana DeGette (D-CO) will provide remarks highlighting the importance of clinical trials awareness and participation.
The event is part of the nationwide Clinical Trials Awareness Week, May 1-5, which is hosted by CCTA. The week’s activities also include a Twitter chat on May 2 and a social media campaign, “Cures begin with clinical trials awareness.”
Clinical trials are an essential step in getting medications approved by the FDA and onto pharmacy shelves for patients. Currently, there is a severe shortage of clinical trial participants, which slows the process of approving medications and moving them to market for patients. One study reported that 11% of clinical trials fail to enroll even one participant.
Consequently, many groundbreaking, life-saving medications remain stuck in the drug development pipeline. With increased participation in clinical trials, however, patients and care providers will have greater access to approved medications.
Clinical Trials Awareness Capitol Hill Policy Roundtable
Wednesday, May 3
11:30 a.m. – 1 p.m.
U.S. Capitol Visitors Center
Room SVC 214
Washington, DC
Panelists:
About The Coalition for Clinical Trials Awareness
The Coalition for Clinical Trials Awareness is a nonprofit group of health care providers, patient advocates, medical researchers and industry and government stakeholders working together to increase public awareness about the importance of clinical trials participation. http://cctawareness.org/
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Zenocutuzumab Shows Durable Efficacy in NRG1 Fusion-Positive Cancers in Phase II eNRGy Trial
February 13th 2025The Phase II eNRGy trial showed durable antitumor activity with zenocutuzumab (Bizengri) in patients with NRG1 fusion–positive cancers, particularly non-small cell lung cancer and pancreatic cancer.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.